Week in review: Epi-on trial, dry eye drug, gold contacts

This week, Glaukos’ investigational epi-on CXL therapy shows promise in phase 3 trials, a new dry eye drug shows an excellent safety profile and contacts infused with gold nanoparticles may help manage red-green color blindness.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553